Get started
Author

Giuseppe Barone

Observed names: Barone G, Barone, G, Barone, Giuseppe, G Barone, G. BARONE, G. Barone
Observed institutions: Università Cattolica del Sacro Cuore, National Health Service, Royal Marsden NHS Foundation Trust, University of Padua, Institute of Cancer Research, Mario Negri Institute for Pharmacological Research, Leeds Teaching Hospitals NHS Trust, Great Ormond Street Hospital, Great Ormond Street Hospital for Children NHS Foundation Trust, Istituto Giannina Gaslini, Agostino Gemelli University Polyclinic, University Hospital Southampton NHS Foundation Trust, Royal Marsden Hospital, Istituto Ortopedico Rizzoli, Centro di Riferimento Oncologico, Ospedale Regina Margherita, Fondazione IRCCS Istituto Nazionale dei Tumori, NIHR Great Ormond Street Hospital Biomedical Research Centre, Regione Lazio, University College London, University of Turin
ORCID: 0000-0003-3264-1913
Observed ORCID: 0000-0003-3264-1913
OpenAlex ID: A5101708497
Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma
2020 · Karin Straathof, Barry Flutter, et al. · Science Translational Medicine · 202
PDF
Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell
2021 · Gerda Kildisiute, Waleed M. Kholosy, et al. · Science Advances · 163
PDF
Embryonal precursors of Wilms tumor
2019 · Tim H. H. Coorens, Taryn D. Treger, et al. · Science · 155
New Strategies in Neuroblastoma: Therapeutic Targeting of MYCN and ALK
2013 · Giuseppe Barone, John Anderson, et al. · Clinical Cancer Research · 127
Factors associated with recurrence and survival length following relapse in patients with neuroblastoma
2016 · Nermine O Basta, Gail C Halliday, et al. · British Journal of Cancer · 103
PDF
Intranasal lidocaine and midazolam for procedural sedation in children
2010 · A. Chiaretti, G. Barone, et al. · Archives of Disease in Childhood · 100
NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children
2009 · A. Chiaretti, G. Barone, et al. · Neurology · 90
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
2019 · Sally L. George, Elisa Izquierdo, et al. · European Journal of Cancer · 86
PDF
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
2020 · Lucas Moreno, Giuseppe Barone, et al. · European Journal of Cancer · 75
PDF
Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma
2020 · Evon Poon, Tong Liang, et al. · Journal of Clinical Investigation · 67
PDF
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
2022 · Mareike Berlak, Elizabeth Tucker, et al. · Molecular Cancer · 63
PDF
Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial
2014 · G. Cefalo, M. Massimino, et al. · Neuro-Oncology · 60
PDF
Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance
2021 · Giuseppe Barone, Ailish Barry, et al. · Pediatric Drugs · 48
Safety and efficacy of fentanyl administered by patient controlled analgesia in children with cancer pain
2006 · A. Ruggiero, G. Barone, et al. · Supportive Care in Cancer · 48
MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
2014 · Giuseppe Barone, Deborah Tweddle, et al. · Current Drug Targets · 46
Topical Nerve Growth Factor as a Visual Rescue Strategy in Pediatric Optic Gliomas
2011 · Benedetto Falsini, Antonio Chiaretti, et al. · Neurorehabilitation and neural repair · 46
Propofol/alfentanil and propofol/ketamine procedural sedation in children with acute lymphoblastic leukaemia: safety, efficacy and their correlation with pain neuromediator expression
2009 · A. CHIARETTI, A. RUGGIERO, et al. · European Journal of Cancer Care · 42
PDF
Role of temozolomide in pediatric brain tumors
2006 · Giuseppe Barone, Palma Maurizi, et al. · Child s Nervous System · 38
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project
2017 · Lucas Moreno, Hubert Caron, et al. · Expert Opinion on Drug Discovery · 37
BEACON-Immuno: Results of the dinutuximab beta (dB) randomization of the BEACON-Neuroblastoma phase 2 trial—A European Innovative Therapies for Children with Cancer (ITCC–International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN) trial.
2022 · Juliet Gray, Lucas Moreno, et al. · Journal of Clinical Oncology · 35
The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism
2006 · Angela Maria Di Francesco, Daniela Meco, et al. · Biochemical Pharmacology · 33
Tumor infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function
2019 · Marina Ollé Hurtado, Jolien Wolbert, et al. · PLoS ONE · 32
PDF
Toxicity and Outcome of Children and Adolescents Participating in Phase I/II Trials of Novel Anticancer Drugs
2013 · Daniel A. Morgenstern, Darren Hargrave, et al. · Journal of Pediatric Hematology/Oncology · 32
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial
2024 · Lucas Moreno, Rebekah Weston, et al. · Journal of Clinical Oncology · 27
The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: A comparative study with SN38 and topotecan
2005 · Angela Maria Di Francesco, Anna Shirley Riccardi, et al. · Biochemical Pharmacology · 26
Works count: 102
Citation count: 2,178
H-index: 26
I10-index: 40
Year
Topic
Type